Viewing Study NCT01332604


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2025-12-25 @ 5:32 PM
Study NCT ID: NCT01332604
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2011-03-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module